Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Axol Bioscience launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of cardiovascular disease.
read more
Axol Bioscience, a biotechnology company specializing in the supply of primary and stem cell-derived human cells for use in disease modelling and drug discovery, announces the launch of its Custom Cell and Tissue Sourcing service.
read more
Axol Bioscience and CENSO Biotechnologies announced the two companies have signed a merger agreement.
read more
Axovant Gene Therapies has signed a strategic partnership with Yposkesi a CDMO for preferred access and reserved capacity for cGMP grade viral vector production.
read more
Axplora has announced a major milestone in its $60 million investment program to expand highly potent API (HPAPI) development and manufacturing at its Farmabios site in Gropello Cairoli, Italy.
read more
Thursday, October 19, 2023
As of November 1st, 2023, Dr. Stephan Haitz will assume the role of President of the Novasep CDMO Business Unit and will become a member of the company's Executive Committee, succeeding Jean Bléhaut, who is departing the company after a distinguished...
read more
Axplora announced the strategic consolidation of ursodeoxycholic acid (UDCA) manufacturing at its Vizag, India site, part of the PharmaZell business unit.
read more
Axplora is strengthening its position in the commercial manufacturing of ADCs with the launch of a cutting-edge payload manufacturing workshop at its Le Mans site (France).
read more
Axplora announced a €35 million expansion at its Farmabios site in Gropello Cairoli, Italy, reinforcing the company’s longstanding commitment to serving the evolving needs of its customers through strategic investment and innovation. This latest ...
read more
Thursday, February 19, 2026
Axplora has announced a multi-million-euro investment to expand lyophilization capabilities at its Le Mans, France, facility, part of a wider program to strengthen antibody-drug conjugate (ADC) manufacturing capacity.
read more
Axplora reported updated EcoVadis sustainability ratings for four of its European manufacturing sites, with one site achieving platinum status and others receiving gold and silver ratings.
read more
Axplora announced the successful installation of a new cGMP pilot unit at its Leverkusen site (Germany), continuing its investment in differentiating and specialized technologies.
read more
Wednesday, February 12, 2025
Axplora announced a €50 million client investment at its Mourenx site in Southwest France, securing its position as a key player in the fight against cardiovascular and metabolic diseases.
read more
Azenta entered an agreement to acquire B Medical Systems S.á r.l and its subsidiaries ("B Medical"). B Medical is a provider of temperature-controlled storage and transportation solutions globally.
read more
Tuesday, February 10, 2026
Azenta announced a strategic partnership with Frontier Space to conduct cutting-edge scientific experiments in space. This collaboration aims to harness the unique benefits of the microgravity environment to accelerate discovery and innovation in ...
read more